OLER ABRAHAM N. 4
4 · Onconova Therapeutics, Inc. · Filed Dec 26, 2019
Insider Transaction Report
Form 4
OLER ABRAHAM N.
VP Corp Dev & Gen Counsel
Transactions
- Award
Stock Option (right to purchase)
2019-12-20+60,000→ 60,000 totalExercise: $0.31Exp: 2029-12-20→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.